首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
First biosimilar antibody nears US approval
被引:0
|
作者
:
Asher Mullard
论文数:
0
引用数:
0
h-index:
0
Asher Mullard
机构
:
来源
:
Nature Reviews Drug Discovery
|
2016年
/ 15卷
关键词
:
D O I
:
暂无
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:151 / 151
相关论文
共 50 条
[1]
First biosimilar antibody nears US approval
Mullard, Asher
论文数:
0
引用数:
0
h-index:
0
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY,
2016,
15
(03)
: 151
-
151
[2]
Gene therapy nears US approval
不详
论文数:
0
引用数:
0
h-index:
0
不详
SCIENCE,
2017,
358
(6361)
: 280
-
280
[3]
ROCHES INVIRASE NEARS US APPROVAL
不详
论文数:
0
引用数:
0
h-index:
0
不详
EUROPEAN CHEMICAL NEWS,
1995,
64
(1692):
: 39
-
39
[4]
Genetically Modified Salmon Nears US FDA Approval as Food
Green, David
论文数:
0
引用数:
0
h-index:
0
机构:
JAFPT, United States
Green, David
JOURNAL OF AQUATIC FOOD PRODUCT TECHNOLOGY,
2011,
20
(01)
: 1
-
1
[5]
FDA's Approval of the First Biosimilar to Bevacizumab
Casak, Sandra J.
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Off Hematol & Oncol Prod, Silver Spring, MD USA
US FDA, Off Hematol & Oncol Prod, Silver Spring, MD USA
Casak, Sandra J.
Lemery, Steven J.
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Off Hematol & Oncol Prod, Silver Spring, MD USA
US FDA, Off Hematol & Oncol Prod, Silver Spring, MD USA
Lemery, Steven J.
Chung, Jee
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Off Biotechnol Prod, Silver Spring, MD USA
US FDA, Off Hematol & Oncol Prod, Silver Spring, MD USA
Chung, Jee
Fuchs, Chana
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Off Biotechnol Prod, Silver Spring, MD USA
US FDA, Off Hematol & Oncol Prod, Silver Spring, MD USA
Fuchs, Chana
Schrieber, Sarah J.
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Off Clin Pharmacol, Silver Spring, MD USA
US FDA, Off Hematol & Oncol Prod, Silver Spring, MD USA
Schrieber, Sarah J.
Chow, Edwin C. Y.
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Off Clin Pharmacol, Silver Spring, MD USA
US FDA, Off Hematol & Oncol Prod, Silver Spring, MD USA
Chow, Edwin C. Y.
Yuan, Weishi
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Off Biostat, Silver Spring, MD USA
US FDA, Off Hematol & Oncol Prod, Silver Spring, MD USA
Yuan, Weishi
Rodriguez, Lisa
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Off Biostat, Silver Spring, MD USA
US FDA, Off Hematol & Oncol Prod, Silver Spring, MD USA
Rodriguez, Lisa
Gwise, Thomas
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Off Biostat, Silver Spring, MD USA
US FDA, Off Hematol & Oncol Prod, Silver Spring, MD USA
Gwise, Thomas
Rowzee, Anne
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Therapeut Biol & Biosimilar Staff, Silver Spring, MD USA
US FDA, Off Hematol & Oncol Prod, Silver Spring, MD USA
Rowzee, Anne
Lim, Sue
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Therapeut Biol & Biosimilar Staff, Silver Spring, MD USA
US FDA, Off Hematol & Oncol Prod, Silver Spring, MD USA
Lim, Sue
Keegan, Patricia
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Off Hematol & Oncol Prod, Silver Spring, MD USA
US FDA, Off Hematol & Oncol Prod, Silver Spring, MD USA
Keegan, Patricia
McKee, Amy E.
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Off Hematol & Oncol Prod, Silver Spring, MD USA
US FDA, Off Hematol & Oncol Prod, Silver Spring, MD USA
McKee, Amy E.
Pazdur, Richard
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Off Hematol & Oncol Prod, Silver Spring, MD USA
US FDA, Oncol Ctr Excellence, Silver Spring, MD USA
US FDA, Off Hematol & Oncol Prod, Silver Spring, MD USA
Pazdur, Richard
CLINICAL CANCER RESEARCH,
2018,
24
(18)
: 4365
-
4370
[6]
FOSCARNET NEARS APPROVAL
DOBKIN, JF
论文数:
0
引用数:
0
h-index:
0
DOBKIN, JF
COMPLICATIONS IN SURGERY,
1991,
10
(09):
: 16
-
16
[7]
First US biosimilar launch
不详
论文数:
0
引用数:
0
h-index:
0
不详
NATURE BIOTECHNOLOGY,
2015,
33
(10)
: 1013
-
1013
[8]
First integrin inhibitor since Tysabri nears approval for IBD
Sheridan, Cormac
论文数:
0
引用数:
0
h-index:
0
Sheridan, Cormac
NATURE BIOTECHNOLOGY,
2014,
32
(03)
: 205
-
207
[9]
First US biosimilar launch
Nature Biotechnology,
2015,
33
: 1013
-
1013
[10]
First integrin inhibitor since Tysabri nears approval for IBD
Cormac Sheridan
论文数:
0
引用数:
0
h-index:
0
Cormac Sheridan
Nature Biotechnology,
2014,
32
: 205
-
206
←
1
2
3
4
5
→